Structure

Physi-Chem Properties

Molecular Weight:  514.4
Volume:  554.849
LogP:  6.284
LogD:  4.92
LogS:  -6.558
# Rotatable Bonds:  19
TPSA:  118.66
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.109
Synthetic Accessibility Score:  4.436
Fsp3:  0.793
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.093
MDCK Permeability:  5.139629138284363e-05
Pgp-inhibitor:  0.052
Pgp-substrate:  0.992
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.976
30% Bioavailability (F30%):  0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.842
Plasma Protein Binding (PPB):  84.70256805419922%
Volume Distribution (VD):  1.021
Pgp-substrate:  18.365407943725586%

ADMET: Metabolism

CYP1A2-inhibitor:  0.039
CYP1A2-substrate:  0.109
CYP2C19-inhibitor:  0.03
CYP2C19-substrate:  0.058
CYP2C9-inhibitor:  0.014
CYP2C9-substrate:  0.061
CYP2D6-inhibitor:  0.95
CYP2D6-substrate:  0.17
CYP3A4-inhibitor:  0.934
CYP3A4-substrate:  0.777

ADMET: Excretion

Clearance (CL):  4.41
Half-life (T1/2):  0.021

ADMET: Toxicity

hERG Blockers:  0.628
Human Hepatotoxicity (H-HT):  0.973
Drug-inuced Liver Injury (DILI):  0.907
AMES Toxicity:  0.027
Rat Oral Acute Toxicity:  0.455
Maximum Recommended Daily Dose:  0.969
Skin Sensitization:  0.954
Carcinogencity:  0.074
Eye Corrosion:  0.003
Eye Irritation:  0.006
Respiratory Toxicity:  0.906

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469423

Natural Product ID:  NPC469423
Common Name*:   Dihomodehydrobatzelladine C
IUPAC Name:   n.a.
Synonyms:   Dihomodehydrobatzelladine C
Standard InCHIKey:  SFLMULQHBGYHRM-RFPXDPOKSA-N
Standard InCHI:  InChI=1S/C29H50N6O2.ClH/c1-3-5-7-8-9-10-12-15-22-21-23-17-18-25-26(27(36)37-20-14-13-19-32-28(30)31)24(16-11-6-4-2)34-29(33-22)35(23)25;/h22-23H,3-21H2,1-2H3,(H4,30,31,32);1H/t22-,23+;/m1./s1
SMILES:  CCCCCCCCCC1CC2CCC3=C(C(=NC(=[N+]23)N1)CCCCC)C(=O)OCCCCN=C(N)N.[Cl-]
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1078458
PubChem CID:   46882526
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001346] Diazines
        • [CHEMONTID:0000075] Pyrimidines and pyrimidine derivatives
          • [CHEMONTID:0001319] Pyrimidinecarboxylic acids and derivatives
            • [CHEMONTID:0002415] Pyrimidinecarboxylic acids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8412 Monanchora arbuscula Species Crambeidae Eukaryota n.a. Caribbean n.a. PMID[19743809]
NPO33489 clathria calla Species Microcionidae Eukaryota n.a. Caribbean n.a. PMID[19743809]
NPO8412 Monanchora arbuscula Species Crambeidae Eukaryota n.a. n.a. n.a. PMID[25924111]
NPO8412 Monanchora arbuscula Species Crambeidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell Line HT-29 Homo sapiens GI50 = 3100.0 nM PMID[451358]
NPT81 Cell Line A549 Homo sapiens GI50 = 4700.0 nM PMID[451358]
NPT139 Cell Line HT-29 Homo sapiens TGI = 5100.0 nM PMID[451358]
NPT82 Cell Line MDA-MB-231 Homo sapiens GI50 = 6100.0 nM PMID[451358]
NPT81 Cell Line A549 Homo sapiens TGI = 8200.0 nM PMID[451358]
NPT139 Cell Line HT-29 Homo sapiens LC50 = 8200.0 nM PMID[451358]
NPT82 Cell Line MDA-MB-231 Homo sapiens TGI = 9800.0 nM PMID[451358]
NPT81 Cell Line A549 Homo sapiens LC50 = 13100.0 nM PMID[451358]
NPT82 Cell Line MDA-MB-231 Homo sapiens LC50 = 15600.0 nM PMID[451358]
NPT1225 Organism Plasmodium falciparum (isolate FcB1 / Columbia) Plasmodium falciparum FcB1/Columbia IC50 = 4500.0 nM PMID[451358]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469423 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9333 High Similarity NPC467022
0.8898 High Similarity NPC469387
0.813 Intermediate Similarity NPC198644
0.813 Intermediate Similarity NPC324722
0.813 Intermediate Similarity NPC311244
0.7706 Intermediate Similarity NPC469424
0.6957 Remote Similarity NPC472736
0.6643 Remote Similarity NPC477519
0.662 Remote Similarity NPC142761
0.6581 Remote Similarity NPC476449
0.6423 Remote Similarity NPC261730
0.64 Remote Similarity NPC469388
0.64 Remote Similarity NPC469389
0.64 Remote Similarity NPC472737
0.6119 Remote Similarity NPC245534
0.5873 Remote Similarity NPC469895
0.5852 Remote Similarity NPC471261
0.5802 Remote Similarity NPC147238
0.5786 Remote Similarity NPC473249
0.5772 Remote Similarity NPC471257
0.5759 Remote Similarity NPC322372
0.5759 Remote Similarity NPC317377
0.5759 Remote Similarity NPC321485
0.5759 Remote Similarity NPC327517
0.5759 Remote Similarity NPC319334
0.5726 Remote Similarity NPC472162
0.5659 Remote Similarity NPC471259
0.56 Remote Similarity NPC241426

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469423 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6176 Remote Similarity NPD4816 Clinical (unspecified phase)
0.594 Remote Similarity NPD6935 Phase 3
0.594 Remote Similarity NPD6936 Clinical (unspecified phase)
0.5896 Remote Similarity NPD6918 Phase 1
0.5873 Remote Similarity NPD2258 Approved
0.5873 Remote Similarity NPD2259 Approved
0.5786 Remote Similarity NPD7746 Phase 1
0.5786 Remote Similarity NPD7747 Phase 1
0.5766 Remote Similarity NPD7739 Clinical (unspecified phase)
0.5725 Remote Similarity NPD7624 Clinical (unspecified phase)
0.5725 Remote Similarity NPD7623 Phase 3
0.563 Remote Similarity NPD869 Approved
0.56 Remote Similarity NPD6077 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data